Moreover, CACNA2D1, which has been detected in human genome-wide association data as a candidate gene for depression65 and bipolar disorder66, has been suggested to be a potential target for depression treatment and rapid antidepressant effects67. This evidence concerns the gene CACNA2D1 and depressive disorder.